Download PDF
Thromb Haemost 1987; 58(02): 792
DOI: 10.1055/s-0038-1645973
Letters to the Editor
Schattauer GmbH Stuttgart

Dermatan Sulfate in Pharmaceutical Heparins

A S Perlin
*   The Dept. of Chemistry, McGill University, Montreal, PQ H3A 2A7, Canada
,
F Sauriol
*   The Dept. of Chemistry, McGill University, Montreal, PQ H3A 2A7, Canada
,
B Cooper
**   The Dept. of Physiology, McGill University, Montreal, PQ H3A 2A7, Canada
,
J Folkman
***   The Children’s Hospital, Harvard Medical School, Boston, MA 02115, USA
› Author Affiliations
Further Information

Publication History

Received 17 February 1987

Accepted after revision 02 April 1987

Publication Date:
27 June 2018 (online)

Also available at
  PDF Download  Permissions and Reprints
 

  • References

  • 1 Jaques LB. Heparin: An old drug with a new paradigm. Science 1979; 206: 528-533
    CrossrefPubMedGoogle Scholar
  • 2 Perlin AS, Mazurek M, Kavanagh LW, Jaques LB. A proton magnetic resonance spectral study of heparin. Carbohydr Res 1978; 7: 369-379
    PubMedGoogle Scholar
  • 3 Perlin AS, Casu B, Sanderson GR, Johnson LF. 220 MHz spectra of heparin, chondroitins, and other mucopolysaccharides. Can J Chem 1970; 48: 2260-2268
    CrossrefPubMedGoogle Scholar
  • 4 Folkman J, Langer R, Linhardt RJ, Haudenschild C, Taylor S. Angiogenesis inhibition and tumor regression caused by heparin or a heparin fragment in the presence of cortisone. Science 1983; 221: 719-725
    CrossrefPubMedGoogle Scholar